Richard C. Wu

3.7k total citations
43 papers, 2.0k citations indexed

About

Richard C. Wu is a scholar working on Oncology, Cardiology and Cardiovascular Medicine and Immunology. According to data from OpenAlex, Richard C. Wu has authored 43 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 14 papers in Cardiology and Cardiovascular Medicine and 13 papers in Immunology. Recurrent topics in Richard C. Wu's work include Cancer Immunotherapy and Biomarkers (12 papers), Cardiac Arrhythmias and Treatments (11 papers) and Atrial Fibrillation Management and Outcomes (9 papers). Richard C. Wu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (12 papers), Cardiac Arrhythmias and Treatments (11 papers) and Atrial Fibrillation Management and Outcomes (9 papers). Richard C. Wu collaborates with scholars based in United States, Germany and Australia. Richard C. Wu's co-authors include Laszlo Radvanyi, George Juang, Patrick Hwu, Tullia C. Bruno, Creg J. Workman, Dario A.A. Vignali, Elisa Ruffo, Chantale Bernatchez, Sunny S. Po and Gordon F. Tomaselli and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Richard C. Wu

39 papers receiving 1.9k citations

Peers

Richard C. Wu

CCM

ONCOL

IMMUN

RNMI

Mark J. Cooper Australia

Christian Maasch Germany

Kelly Q. Schoenfelt United States

J G Porter United States

Arnd Heuser Germany

C L Hsieh United States

Walter C. Thompson United States

Luis H. Arroyo United States

Wenze Wang China

Aileen M. Healy United States

Mark J. Cooper Australia

Richard C. Wu

834 ×0.9

CCM

232 ×0.4

ONCOL

71 ×0.1

IMMUN

446 ×1.0

69 ×0.4

RNMI

Citations per year, relative to Richard C. Wu Richard C. Wu (= 1×) peers Mark J. Cooper

Countries citing papers authored by Richard C. Wu

Since Specialization

Citations

This map shows the geographic impact of Richard C. Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard C. Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard C. Wu more than expected).

Fields of papers citing papers by Richard C. Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard C. Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard C. Wu. The network helps show where Richard C. Wu may publish in the future.

Co-authorship network of co-authors of Richard C. Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Richard C. Wu. A scholar is included among the top collaborators of Richard C. Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard C. Wu. Richard C. Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Núñez, Fernando M., et al.. (2025). Exceptional Response of Therapy-Resistant SF3B1 Mutant Conjunctival Melanoma to Nivolumab/LAG3 Inhibitor Relatlimab Combination Therapy: A Case Report. Case Reports in Oncology. 18(1). 381–388.

Rosenblatt, Anna, et al.. (2024). PO-01-031 STELLATE GANGLION BLOCK AS A BRIDGE TO STEREOTACTIC ABLATIVE BODY RADIOTHERAPY IN ELECTRICAL STORM. Heart Rhythm. 21(5). S225–S225.

Chen, Chia‐Hung, et al.. (2024). Laparoscopic training workshop to assess medical students’ skill acquisition and interest in surgical careers. BMC Medical Education. 24(1). 721–721. 1 indexed citations

Martin, Brian J., Elshad Hasanov, Richard C. Wu, et al.. (2024). The 31-GEP to identify patients with localized cutaneous melanoma at the highest risk of metastasis to the central nervous system.. Journal of Clinical Oncology. 42(16_suppl). 9530–9530. 2 indexed citations

Chahoud, Jad, Yousef Zakharia, Meredith McKean, et al.. (2024). Phase 1/2 study of XTX202, a tumor-activated IL-2βγ, in advanced solid tumors.. Journal of Clinical Oncology. 42(16_suppl). 2595–2595. 1 indexed citations

Allen, Carter, Dionisia Quiroga, Emily Schwarz, et al.. (2023). Single-Cell RNA-Seq Analysis of Patient Myeloid-Derived Suppressor Cells and the Response to Inhibition of Bruton's Tyrosine Kinase. Molecular Cancer Research. 22(3). 308–321. 4 indexed citations

Shah, Manan, Saba Shafi, Kari Kendra, Claire F. Verschraegen, & Richard C. Wu. (2023). Real-world comparison between 6 weeks versus 3 weeks adjuvant pembrolizumab in high-risk stage IIB-IIID cutaneous malignant melanoma: Experience from an academic cancer center.. Journal of Clinical Oncology. 41(16_suppl). 9545–9545. 1 indexed citations

Husain, Marium, Rebecca Hoyd, Alexa Meara, et al.. (2023). De-correlating immune checkpoint inhibitor toxicity and response in melanoma via the microbiome.. Journal of Clinical Oncology. 41(16_suppl). 9569–9569. 2 indexed citations

Li, Mingjia, Natalie Spaccarelli, Kari Kendra, Richard C. Wu, & Claire F. Verschraegen. (2021). Refractory dermatitis contributed by pityriasis versicolor: a case report. Journal of Medical Case Reports. 15(1). 212–212. 3 indexed citations

10.

Chacon, Jessica, Richard C. Wu, Pariya Sukhumalchandra, et al.. (2013). Co-Stimulation through 4-1BB/CD137 Improves the Expansion and Function of CD8+ Melanoma Tumor-Infiltrating Lymphocytes for Adoptive T-Cell Therapy. PLoS ONE. 8(4). e60031–e60031. 104 indexed citations

11.

Wu, Richard C., Shujuan Liu, Jessica Chacon, et al.. (2012). Detection and Characterization of a Novel Subset of CD8+CD57+ T Cells in Metastatic Melanoma with an Incompletely Differentiated Phenotype. Clinical Cancer Research. 18(9). 2465–2477. 19 indexed citations

12.

Haymaker, Cara, Richard C. Wu, Chantale Bernatchez, & Laszlo Radvanyi. (2012). PD-1 and BTLA and CD8⁺T-cell “exhaustion” in cancer. OncoImmunology. 1(5). 735–738. 65 indexed citations

13.

Wu, Richard C., Patrick Hwu, & Laszlo Radvanyi. (2012). New insights on the role of CD8⁺CD57⁺T-cells in cancer. OncoImmunology. 1(6). 954–956. 20 indexed citations

14.

Chacon, Jessica, Yi‐Jun Wang, Richard C. Wu, Patrick Hwu, & Laszlo Radvanyi. (2011). Costimulation through 4-1BB/CD137 improves the expansion and function of CD8+ melanoma tumor-infiltrating lymphocytes for adoptive T-cell therapy (66.21). The Journal of Immunology. 186(1_Supplement). 66.21–66.21. 1 indexed citations

15.

Zhou, Jing, Benjamin J. Scherlag, William S. Yamanashi, et al.. (2006). Experimental Model Simulating Right Ventricular Outflow Tract Tachycardia: A Novel Technique to Initiate RVOT‐VT. Journal of Cardiovascular Electrophysiology. 17(7). 771–775. 20 indexed citations

16.

Nakagawa, Hiroshi, Katsuaki Yokoyama, Richard C. Wu, et al.. (2006). AB3-5. Heart Rhythm. 3(5). S6–S6. 3 indexed citations

17.

Po, Sunny S., Benjamin J. Scherlag, William S. Yamanashi, et al.. (2006). Experimental model for paroxysmal atrial fibrillation arising at the pulmonary vein-atrial junctions. Heart Rhythm. 3(2). 201–208. 173 indexed citations

18.

Akar, Fadi G., Richard C. Wu, Isabelle Deschênes, et al.. (2004). Phenotypic differences in transient outward K⁺ current of human and canine ventricular myocytes: insights into molecular composition of ventricular I_to. American Journal of Physiology-Heart and Circulatory Physiology. 286(2). H602–H609. 70 indexed citations

19.

Wu, Richard C., Ronald D. Berger, & Hugh Calkins. (2002). Catheter ablation of atrial flutter and macroreentrant atrial tachycardia. Current Opinion in Cardiology. 17(1). 58–64. 8 indexed citations

20.

Chaplin, David, M. Sue Kirkman, Richard C. Wu, et al.. (1991). Different Isozymes of Mouse 11/ß-Hydroxylase Produce Mineralocorticoids and Glucocorticoids. Molecular Endocrinology. 5(12). 1853–1861. 149 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact